Trial
NCT00483561
Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI)
Condition
Prostate Cancer
Intervention
Gefitinib plus etoposide
Why stopped
PI left UNMC
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-13